Occludin anticorps (C-Term)
Aperçu rapide pour Occludin anticorps (C-Term) (ABIN2743388)
Antigène
Voir toutes Occludin (OCLN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Purification
- Protein A purified
-
Immunogène
-
GST fusion protein consisting of the C-terminal region (~150aa) of human occludin.
Type of Immunogen: Fusion protein -
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Approved: ELISA, ICC, IF (2.5 - 5 μg/mL), WB
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 4.0 mg/mL BSA, 1 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Protect from light.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles. Protect from light.
-
-
- Occludin (OCLN)
-
Autre désignation
- OCLN / Occludin
-
Sujet
-
Name/Gene ID: OCLN
Synonyms: OCLN, Occludin, BLCPMG -
ID gène
- 100506658
-
Pathways
- Cell-Cell Junction Organization, Hepatitis C
Antigène
-